Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/15/2010 | EP2261356A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261355A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261354A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261353A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261352A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261351A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261350A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261349A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261348A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261347A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261346A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261345A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261344A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261343A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261342A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261341A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261340A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261339A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261338A2 Neisseria meningitidis antigens and compositions |
12/15/2010 | EP2261337A1 DNA sequence and recombinant production of group 4 major allergens from cereals |
12/15/2010 | EP2261336A1 DNA sequence and recombinant production of group 4 major allergens from cereals |
12/15/2010 | EP2261335A1 Compositions and methods for increasing bone mineralisation |
12/15/2010 | EP2261334A2 Modified polynucleotides for use in RNA interference |
12/15/2010 | EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides |
12/15/2010 | EP2261332A2 Libraries of recombinant chimeric proteins |
12/15/2010 | EP2261331A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
12/15/2010 | EP2261329A2 Subtilases |
12/15/2010 | EP2261326A1 Novel trichoderma genes |
12/15/2010 | EP2261312A1 Extraction and Winterization of Lipids from Oilseed and Microbial Sources |
12/15/2010 | EP2261250A1 Albumin fusion proteins |
12/15/2010 | EP2261249A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261248A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261247A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS) |
12/15/2010 | EP2261243A2 Hemopexin-like structure as polypeptide-scaffold |
12/15/2010 | EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/15/2010 | EP2261239A2 Multiple variants of meningococcal protein NMB1870 |
12/15/2010 | EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
12/15/2010 | EP2261228A1 Promoters for regulation of gene expression in plant roots |
12/15/2010 | EP2261227A1 Promoters for regulation of gene expression in plant roots |
12/15/2010 | EP2260863A1 Prophylactic/therapeutic agent for infectious disease |
12/15/2010 | EP2260105A2 Production and use of plant degrading materials |
12/15/2010 | EP2260104A1 Corynebacteria using carbon sources containing glycerol and process for producing fermentation product using the same |
12/15/2010 | EP2260103A2 Direct selection of structurally defined aptamers |
12/15/2010 | EP2260102A1 Treating cancer by down-regulating frizzled-4 and/or frizzled-1 |
12/15/2010 | EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes |
12/15/2010 | EP2260099A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
12/15/2010 | EP2260098A1 Treating cancer |
12/15/2010 | EP2260054A1 Purified immunoglobulin fusion proteins and methods of their purification |
12/15/2010 | EP2259802A1 Drug fusions and conjugates |
12/15/2010 | EP2259674A1 4 desaturase and its use in making polyunsaturated fatty acids |
12/15/2010 | EP1883702B1 Pericarp-preferred regulatory element |
12/15/2010 | EP1883700B1 Plants having increased yield and a method for making the same |
12/15/2010 | EP1841878B1 Method for the generation of virus producing cell lines and cell lines |
12/15/2010 | EP1828380B1 Neutral cellulase catalytic core and method of producing same |
12/15/2010 | EP1758998B1 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
12/15/2010 | EP1749098B1 Chimeric adenoviruses for use in cancer treatment |
12/15/2010 | EP1725668B1 Genetically modified plants and their applications in phytoremediation. |
12/15/2010 | EP1687417B1 Plants with reduced activity of a class 3 branching enzyme |
12/15/2010 | EP1673451B1 Protease variants |
12/15/2010 | EP1654363B1 Oligonucleotide analog and method for treating flavivirus infections |
12/15/2010 | EP1534842B1 Stress tolerance and delayed senescence in plants |
12/15/2010 | EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
12/15/2010 | EP1503985B1 Polypeptides and biosynthetic pathways |
12/15/2010 | EP1444523B1 Screening for hepatitis c virus entry inhibitors |
12/15/2010 | EP1123977B1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
12/15/2010 | EP1112077B1 Method for detection of biological factors in epidermis |
12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |
12/15/2010 | EP1053001B1 Novel mixed amylin activity compounds |
12/15/2010 | EP1001987B1 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
12/15/2010 | CN1847399B Isolated luciferases and the use thereof |
12/15/2010 | CN1802386B GLP-1 analog fusion proteins |
12/15/2010 | CN1665932B Vectors with modified protease-dependent tropism |
12/15/2010 | CN101918595A Enzymes for amplification and copying bisulphite modified nucleic acids |
12/15/2010 | CN101918586A Fused gene(s) |
12/15/2010 | CN101918585A Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease |
12/15/2010 | CN101918577A Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same |
12/15/2010 | CN101918575A Novel gene sms 44 |
12/15/2010 | CN101918566A Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system |
12/15/2010 | CN101918565A Replication-defective arenavirus vectors |
12/15/2010 | CN101918564A Quadruple transgenic non-human animal |
12/15/2010 | CN101918563A Compositions and methods for the suppression of target polynucleotides |
12/15/2010 | CN101918562A Compositions and methods for the suppression of target polynucleotides from lepidoptera |
12/15/2010 | CN101918561A Chimeric construct of mungbean yellow mosaic india virus (MYMIV) and its uses thereof |
12/15/2010 | CN101918560A Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT2 polypeptides and homologs thereof |
12/15/2010 | CN101918559A Modifying glycoprotein production in plants |
12/15/2010 | CN101918558A Treatment and prevention of influenza |
12/15/2010 | CN101918557A Method of genetically altering and producing allergy free cats |
12/15/2010 | CN101918556A Cell permeable NM23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
12/15/2010 | CN101918555A Humanized anti-alpha9 integrin antibodies and the uses thereof |
12/15/2010 | CN101918554A Complex of polysaccharide and double-stranded RNA |
12/15/2010 | CN101918553A Novel glucose dehydrogenase |
12/15/2010 | CN101918552A Method for determination of inflammatory disease by using single nucleotide polymorphism in BRCA1-related protein (BRAP) gene |
12/15/2010 | CN101918551A Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase |
12/15/2010 | CN101918550A Primer set and probe for detection of human papillomavirus |
12/15/2010 | CN101918549A Improved humanized anti-human alpha9-integrin antibody |
12/15/2010 | CN101918548A Recombinantly modified plasmin |
12/15/2010 | CN101918547A Recombinant elastase proteins and methods of manufacturing and use thereof |
12/15/2010 | CN101918544A Method for increasing immunoreactivity |
12/15/2010 | CN101918539A Light-driven CO2 reduction to organic compounds to serve as fuels or as industrial half products by an autotroph containing a fermentative gene cassette |